Advanced search
Publication Cover
Journal of Medical Economics Volume 27, 2024 - Issue 1
Submit an article Journal homepage
1,705
Views
0
CrossRef citations to date
0
Altmetric
Oncology

An updated cost-effectiveness analysis of axicabtagene ciloleucel in second-line large B-cell lymphoma patients in the United States

Olalekan O. Oluwolea Vanderbilt University Medical Centre, Nashville, TN, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8525-9641View further author information
ORCID Icon,
Anik R. Patelb Kite, a Gilead company, Santa Monica, CA, USAView further author information
,
Sachin Vadgamab Kite, a Gilead company, Santa Monica, CA, USAView further author information
,
Nathaniel J. Smithc Maple Health Group, New York, NY, USAView further author information
,
Rob Blissettc Maple Health Group, New York, NY, USAView further author information
,
Chaoling Fengb Kite, a Gilead company, Santa Monica, CA, USAView further author information
,
Michael Dickinsond Peter MacCallum Cancer Centre, Melbourne, AustraliaView further author information
,
Patrick B. Johnstone Mayo Clinic, Rochester, MN, USAView further author information
&
Miguel-Angel Peralesf Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA;g Department of Medicine, Weill Cornell Medical College, New York, NY, USAORCID Iconhttps://orcid.org/0000-0002-5910-4571View further author information
ORCID Icon show all
Pages 77-83 | Received 24 Oct 2023, Accepted 30 Nov 2023, Published online: 19 Dec 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.